DRAZAY Trademark

Trademark Overview

On Wednesday, April 27, 2011, a trademark application was filed for DRAZAY with the United States Patent and Trademark Office. The USPTO has given the DRAZAY trademark a serial number of 85306193. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 13, 2014. This trademark is owned by Glaxo Group Limited. The DRAZAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
drazay

General Information

Serial Number85306193
Word MarkDRAZAY
Filing DateWednesday, April 27, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 13, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 2, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, October 14, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 13, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 7, 2014EXTENSION 5 GRANTED
Tuesday, February 25, 2014EXTENSION 5 FILED
Tuesday, February 25, 2014TEAS EXTENSION RECEIVED
Friday, August 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2013EXTENSION 4 GRANTED
Wednesday, August 14, 2013EXTENSION 4 FILED
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 9, 2013EXTENSION 3 GRANTED
Wednesday, February 27, 2013EXTENSION 3 FILED
Saturday, March 9, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 27, 2013TEAS EXTENSION RECEIVED
Thursday, September 6, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 5, 2012EXTENSION 2 GRANTED
Friday, August 31, 2012EXTENSION 2 FILED
Wednesday, September 5, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 31, 2012TEAS EXTENSION RECEIVED
Friday, February 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2012EXTENSION 1 GRANTED
Wednesday, February 8, 2012EXTENSION 1 FILED
Wednesday, February 8, 2012TEAS EXTENSION RECEIVED
Tuesday, September 6, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2011PUBLISHED FOR OPPOSITION
Friday, June 3, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, June 3, 2011ASSIGNED TO LIE
Thursday, May 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2011ASSIGNED TO EXAMINER
Monday, May 2, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 30, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

drazay pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological